Veradermics affiliate plans sale of 87K MANE shares

MANE has a planned resale of restricted securities under Form 144.

Rhea-AI Filing Summary

MANE has a planned resale of restricted securities under Form 144. The filing lists up to 87,000 shares of common stock to be sold through J.P. Morgan Securities LLC on the NYSE, with a proposed sale date of August 17, 2026.

The 87,000 shares are composed of 3,452 shares associated with stock options originally dated March 24, 2020, and 83,548 founder shares from the same date. These are sales by an existing holder, not a new issuance by the company.

Key Figures

Shares of common stock to be sold: 87,000 shares Stock option shares included: 3,452 shares Founder shares included: 83,548 shares +1 more

4 metrics

Shares of common stock to be sold 87,000 shares Planned sale of MANE common stock through J.P. Morgan Securities LLC

Stock option shares included 3,452 shares Portion of the 87,000 MANE shares related to a stock option dated 03/24/2020

Founder shares included 83,548 shares Portion of the 87,000 MANE shares classified as founder shares dated 03/24/2020

Proposed sale date 08/17/2026 Date associated with the planned sale of 87,000 MANE shares on the NYSE

Key Terms

Form 144, Founder Shares, Stock Option

3 terms

Form 144 regulatory

"has a planned resale of restricted securities under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Founder Shares financial

"Founder Shares | Issuer | | | 83548 | 03/24/2020"

Founder shares are the ownership stakes given to the people who start a company, often with extra voting power or protections compared with ordinary shares. For investors, they matter because founders’ control and incentives influence decisions about strategy, hiring, and whether the company sells or stays independent — like a family that keeps majority voting rights in a household decision. High founder ownership can mean stable leadership but also a risk that outside shareholders have less influence.

Stock Option financial

"Stock Option | Issuer | | | 3452 | 08/17/2026"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MANE's Form 144 filing disclose about planned share sales?

The Form 144 discloses an intent to sell up to 87,000 shares of MANE common stock through J.P. Morgan Securities LLC on the NYSE on or after August 17, 2026, consisting of stock option shares and founder shares.

How many MANE shares are planned to be sold through J.P. Morgan Securities LLC?

The filing lists a planned sale of 87,000 shares of MANE common stock. These shares are to be sold through J.P. Morgan Securities LLC on the NYSE, as part of a resale of restricted or control securities by an existing holder.

What types of MANE securities are included in the 87,000 shares on Form 144?

The 87,000 shares consist of 3,452 shares related to a stock option dated March 24, 2020, and 83,548 founder shares also dated March 24, 2020. Both categories are listed as securities to be sold by the issuer’s affiliate.

When are the MANE shares on this Form 144 expected to be sold?

The Form 144 indicates a proposed sale date of August 17, 2026. This date applies to the planned sale of 87,000 MANE common shares through J.P. Morgan Securities LLC on the NYSE, subject to market and regulatory conditions.

Is MANE issuing new shares in this Form 144 filing?

No. The Form 144 relates to a resale by an existing holder of MANE common stock. It covers 87,000 already-issued shares, including stock option shares and founder shares, rather than a new primary issuance by the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 05:40 PM Accepted by SEC EDGAR 08/17/2026 - 05:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002107508
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERADERMICS INC
SEC File Number	001-43097
Address of Issuer	470 James Street New Haven CONNECTICUT 06513
Phone	228-372-3376
Name of Person for Whose Account the Securities are To Be Sold	Timothy Durso
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	87000	9681360	41780136	08/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/17/2026	Stock Option	Issuer			3452	08/17/2026	Cash
Common	03/24/2020	Founder Shares	Issuer			83548	03/24/2020	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Timothy Durso.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)